Pharma

All articles by Pharma

With Facebook set to curtail health-related targeting, experts assess pharma brand impact
With Facebook set to curtail health-related targeting, experts assess pharma brand impact
Marc Iskowitz
December 1, 2021
9:36 am

The change may spur advertisers to build their own audiences to engage patients and HCPs on the social platform.

Five things for health marketers to know: Wednesday, December 1, 2021
Five things for health marketers to know: Wednesday, December 1, 2021
Lecia Bushak
December 1, 2021
5:00 am

CDC recommends booster shots for all adults; FDA discusses authorization of Merck antiviral; Immunogen drug shrinks tumors in ovarian cancer patients.

The orphan drug launch, reconsidered
The orphan drug launch, reconsidered
MM+M Staff
November 30, 2021
1:00 pm

Charlie Gayer, chief commercial officer for BioCryst Pharmaceuticals, talks about how his company, which recently launched an oral medicine into a crowded category, used analytics to rethink the rare-disease drug launch.

Five things for health marketers to know: Tuesday, November 30, 2021
Five things for health marketers to know: Tuesday, November 30, 2021
Lecia Bushak
November 30, 2021
5:00 am

Biden: FDA and CDC ready to move quickly on Omicron variant; Blueprint buys Lengo Therapeutics; Yvonne Greenstreet to become Alnylam CEO.

Maverick Novartis shaking up go-to-market strategy for new heart drug
Maverick Novartis shaking up go-to-market strategy for new heart drug
Marc Iskowitz
November 29, 2021
10:00 am

The drugmaker is setting aside the typical rep-driven model for the U.S. launch of Leqvio (inclisiran). But can it avoid access pitfalls?

Five things for health marketers to know: Monday, November 29, 2021
Five things for health marketers to know: Monday, November 29, 2021
Lecia Bushak
November 29, 2021
5:00 am

COVID-19 cases surge in Europe; FDA places clinical hold on Kura Oncology trial; Immunotherapy companies tackle food allergies.

Five things for health marketers to know: Wednesday, November 24, 2021
Five things for health marketers to know: Wednesday, November 24, 2021
Lecia Bushak
November 24, 2021
5:00 am

Biden administration has no plans to reimpose COVID-19 lockdown; former FDA chief Hahn called to testify before Congress; federal jury finds CVS, Walgreens and Walmart responsible in opioid crisis.

Five things for health marketers to know: Tuesday, November 23, 2021
Five things for health marketers to know: Tuesday, November 23, 2021
Lecia Bushak
November 23, 2021
5:00 am

90% of federal employees have received at least one dose of COVID-19 vaccine; Elizabeth Holmes testifies for first time in fraud trial; Sanofi partners with Baidu to pursue mRNA pipeline.

Five things for health marketers to know: Monday, November 22, 2021
Five things for health marketers to know: Monday, November 22, 2021
Lecia Bushak
November 22, 2021
5:00 am

FDA authorizes Pfizer, Moderna boosters for all adults; Democrats’ pricing proposal clears hurdle; FDA places BioNTech skin cancer therapy on fast track.

Five things for health marketers to know: Friday, November 19, 2021
Five things for health marketers to know: Friday, November 19, 2021
Lecia Bushak
November 19, 2021
5:00 am

U.S. buys 10 million courses of Pfizer COVID-19 pill; CVS Health to close 900 stores as part of move toward health services; Novo Nordisk acquires RNAi pioneer Dicerna for $3.3 billion.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners